North America Follicle Stimulating Hormone Market by Manufacturers, Countries, Type and Application, Forecast to 2022
- GLO1453630
- 115 Pages
- August 2017
- Healthcare
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
In this report, it refers to follicle stimulating hormone drugs for human use. 1 dose is equal to 75 IU."
Scope of the Report:
This report focuses on the Follicle Stimulating Hormone in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Market Segment by Countries, covering
United States
Canada
Mexico
Market Segment by Type, covers
Recombinant FSH
Urinary FSH
Market Segment by Applications, can be divided into
Infertility Treatment
Assisted Reproductive Technology
There are 15 Chapters to deeply display the North America Follicle Stimulating Hormone market.
Chapter 1, to describe Follicle Stimulating Hormone Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Follicle Stimulating Hormone, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Follicle Stimulating Hormone, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Follicle Stimulating Hormone market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Follicle Stimulating Hormone Research Findings and Conclusion, Appendix, methodology and data source
1 Market Overview
1.1 Follicle Stimulating Hormone Introduction
1.2 Market Analysis by Type
1.2.1 Recombinant FSH
1.2.2 Urinary FSH
1.3 Market Analysis by Applications
1.3.1 Infertility Treatment
1.3.2 Assisted Reproductive Technology
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck Serono
2.1.1 Profile
2.1.2 Follicle Stimulating Hormone Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Merck Serono Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Merck Serono News
2.2 MSD
2.2.1 Profile
2.2.2 Follicle Stimulating Hormone Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 MSD Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 MSD News
2.3 IBSA
2.3.1 Profile
2.3.2 Follicle Stimulating Hormone Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 IBSA Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 IBSA News
2.4 Ferring
2.4.1 Profile
2.4.2 Follicle Stimulating Hormone Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Ferring Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Ferring News
2.5 Livzon
2.5.1 Profile
2.5.2 Follicle Stimulating Hormone Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Livzon Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Livzon News
2.6 Techwell
2.6.1 Profile
2.6.2 Follicle Stimulating Hormone Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Techwell Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Techwell News
2.7 GenSci
2.7.1 Profile
2.7.2 Follicle Stimulating Hormone Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 GenSci Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 GenSci News
3 North America Follicle Stimulating Hormone Market Competition, by Manufacturer
3.1 North America Follicle Stimulating Hormone Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Follicle Stimulating Hormone Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Follicle Stimulating Hormone Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Follicle Stimulating Hormone Manufacturer Market Share
3.4.2 Top 5 Follicle Stimulating Hormone Manufacturer Market Share
3.5 Market Competition Trend
4 North America Follicle Stimulating Hormone Market Analysis by Countries
4.1 North America Follicle Stimulating Hormone Sales Market Share by Countries
4.2 North America Follicle Stimulating Hormone Sales by Countries (2012-2017)
4.3 North America Follicle Stimulating Hormone Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Follicle Stimulating Hormone by Type
5.1 North America Follicle Stimulating Hormone Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Follicle Stimulating Hormone Sales and Market Share by Type (2012-2017)
5.1.2 North America Follicle Stimulating Hormone Revenue and Market Share by Type (2012-2017)
5.2 Recombinant FSH Sales Growth and Price
5.2.1 North America Recombinant FSH Sales Growth (2012-2017)
5.2.2 North America Recombinant FSH Price (2012-2017)
5.3 Urinary FSH Sales Growth and Price
5.3.1 North America Urinary FSH Sales Growth (2012-2017)
5.3.2 North America Urinary FSH Price (2012-2017)
6 North America Market Segmentation Follicle Stimulating Hormone by Application
6.1 North America Follicle Stimulating Hormone Sales Market Share by Application (2012-2017)
6.2 Infertility Treatment Sales Growth (2012-2017)
6.3 Assisted Reproductive Technology Sales Growth (2012-2017)
7 United States Follicle Stimulating Hormone Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Follicle Stimulating Hormone Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Follicle Stimulating Hormone Sales and Market Share by Type
7.3 United States Follicle Stimulating Hormone Sales by Application (2012-2017)
7.4 United States Follicle Stimulating Hormone Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Follicle Stimulating Hormone Sales and Market Share by Manufacturer
7.4.2 United States Follicle Stimulating Hormone Revenue and Market Share by Manufacturer
7.5 United States Follicle Stimulating Hormone Export and Import (2012-2017)
8 Canada Follicle Stimulating Hormone Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Follicle Stimulating Hormone Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Follicle Stimulating Hormone Sales and Market Share by Type
8.3 Canada Follicle Stimulating Hormone Sales by Application (2012-2017)
8.4 Canada Follicle Stimulating Hormone Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Follicle Stimulating Hormone Sales and Market Share by Manufacturer
8.4.2 Canada Follicle Stimulating Hormone Revenue and Market Share by Manufacturer
8.5 Canada Follicle Stimulating Hormone Export and Import (2012-2017)
9 Mexico Follicle Stimulating Hormone Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Follicle Stimulating Hormone Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Follicle Stimulating Hormone Sales and Market Share by Type
9.3 Mexico Follicle Stimulating Hormone Sales by Application (2012-2017)
9.4 Mexico Follicle Stimulating Hormone Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Follicle Stimulating Hormone Sales and Market Share by Manufacturer
9.4.2 Mexico Follicle Stimulating Hormone Revenue and Market Share by Manufacturer
9.5 Mexico Follicle Stimulating Hormone Export and Import (2012-2017)
10 Follicle Stimulating Hormone Market Forecast (2017-2022)
10.1 North America Follicle Stimulating Hormone Sales, Revenue and Growth Rate (2017-2022)
10.2 Follicle Stimulating Hormone Market Forecast by Countries (2017-2022)
10.2.1 United States Follicle Stimulating Hormone Forecast (2017-2022)
10.2.2 Canada Follicle Stimulating Hormone Forecast (2017-2022)
10.2.3 Mexico Follicle Stimulating Hormone Forecast (2017-2022)
10.3 Follicle Stimulating Hormone Market Forecast by Type (2017-2022)
10.4 Follicle Stimulating Hormone Market Forecast by Application (2017-2022)
11 Follicle Stimulating Hormone Manufacturing Cost Analysis
11.1 Follicle Stimulating Hormone Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Follicle Stimulating Hormone
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Follicle Stimulating Hormone Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Follicle Stimulating Hormone Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
Figure Follicle Stimulating Hormone Picture
Table Product Specifications of Follicle Stimulating Hormone
Figure North America Sales Market Share of Follicle Stimulating Hormone by Types in 2016
Table Types of Follicle Stimulating Hormone
Figure Recombinant FSH Picture
Table Major Manufacturers of Recombinant FSH
Figure Urinary FSH Picture
Table Major Manufacturers of Urinary FSH
Table North America Follicle Stimulating Hormone Sales Market Share by Applications in 2016
Table Applications of Follicle Stimulating Hormone
Figure Infertility Treatment Picture
Figure Assisted Reproductive Technology Picture
Figure United States Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2012-2022)
Table Merck Serono Basic Information, Manufacturing Base and Competitors
Table Merck Serono Follicle Stimulating Hormone Type and Applications
Table Merck Serono Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MSD Basic Information, Manufacturing Base and Competitors
Table MSD Follicle Stimulating Hormone Type and Applications
Table MSD Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table IBSA Basic Information, Manufacturing Base and Competitors
Table IBSA Follicle Stimulating Hormone Type and Applications
Table IBSA Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ferring Basic Information, Manufacturing Base and Competitors
Table Ferring Follicle Stimulating Hormone Type and Applications
Table Ferring Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Livzon Basic Information, Manufacturing Base and Competitors
Table Livzon Follicle Stimulating Hormone Type and Applications
Table Livzon Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Techwell Basic Information, Manufacturing Base and Competitors
Table Techwell Follicle Stimulating Hormone Type and Applications
Table Techwell Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GenSci Basic Information, Manufacturing Base and Competitors
Table GenSci Follicle Stimulating Hormone Type and Applications
Table GenSci Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Follicle Stimulating Hormone Sales by Manufacturer (2016-2017)
Figure North America Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2016
Figure North America Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2017
Table North America Follicle Stimulating Hormone Revenue by Manufacturer (2016-2017)
Figure North America Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2016
Figure North America Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2017
Table North America Follicle Stimulating Hormone Price by Manufacturers (2016-2017)
Figure Top 3 Follicle Stimulating Hormone Manufacturer Market Share in 2016
Figure Top 3 Follicle Stimulating Hormone Manufacturer Market Share in 2017
Figure Top 5 Follicle Stimulating Hormone Manufacturer Market Share in 2016
Figure Top 5 Follicle Stimulating Hormone Manufacturer Market Share in 2017
Figure North America Follicle Stimulating Hormone Sales and Growth (2012-2017)
Table North America Follicle Stimulating Hormone Sales by Countries (2012-2017)
Table North America Follicle Stimulating Hormone Sales Market Share by Countries (2012-2017)
Figure North America 2012 Follicle Stimulating Hormone Sales Market Share by Countries
Figure North America 2016 Follicle Stimulating Hormone Sales Market Share by Countries
Figure North America Follicle Stimulating Hormone Revenue and Growth (2012-2017)
Table North America Follicle Stimulating Hormone Revenue by Countries (2012-2017)
Table North America Follicle Stimulating Hormone Revenue Market Share by Countries (2012-2017)
Table North America 2012 Follicle Stimulating Hormone Revenue Market Share by Countries
Table North America 2016 Follicle Stimulating Hormone Revenue Market Share by Countries
Table North America Follicle Stimulating Hormone Sales by Type (2012-2017)
Table North America Follicle Stimulating Hormone Sales Share by Type (2012-2017)
Table North America Follicle Stimulating Hormone Revenue by Type (2012-2017)
Table North America Follicle Stimulating Hormone Revenue Share by Type (2012-2017)
Figure North America Recombinant FSH Sales Growth (2012-2017)
Figure North America Recombinant FSH Price (2012-2017)
Figure North America Urinary FSH Sales Growth (2012-2017)
Figure North America Urinary FSH Price (2012-2017)
Table North America Follicle Stimulating Hormone Sales by Application (2012-2017)
Table North America Follicle Stimulating Hormone Sales Share by Application (2012-2017)
Figure North America Infertility Treatment Sales Growth (2012-2017)
Figure North America Assisted Reproductive Technology Sales Growth (2012-2017)
Figure United States Follicle Stimulating Hormone Revenue and Growth (2012-2017)
Figure United States Follicle Stimulating Hormone Sales and Growth (2012-2017)
Table United States Follicle Stimulating Hormone Sales by Type (2012-2017)
Table United States Follicle Stimulating Hormone Sales Market Share by Type (2012-2017)
Table United States Follicle Stimulating Hormone Sales by Application (2012-2017)
Table United States Follicle Stimulating Hormone Sales Market Share by Application (2012-2017)
Table United States Follicle Stimulating Hormone Sales by Manufacturer (2016-2017)
Figure United States Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2016
Figure United States Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2017
Table United States Follicle Stimulating Hormone Revenue by Manufacturer (2016-2017)
Figure United States Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2016
Figure United States Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2017
Table United States Follicle Stimulating Hormone Export and Import (2012-2017)
Figure Canada Follicle Stimulating Hormone Revenue and Growth (2012-2017)
Figure Canada Follicle Stimulating Hormone Sales and Growth (2012-2017)
Table Canada Follicle Stimulating Hormone Sales by Type (2012-2017)
Table Canada Follicle Stimulating Hormone Sales Market Share by Type (2012-2017)
Table Canada Follicle Stimulating Hormone Sales by Application (2012-2017)
Table Canada Follicle Stimulating Hormone Sales Market Share by Application (2012-2017)
Table Canada Follicle Stimulating Hormone Sales by Manufacturer (2016-2017)
Figure Canada Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2016
Figure Canada Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2017
Table Canada Follicle Stimulating Hormone Revenue by Manufacturer (2016-2017)
Figure Canada Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2016
Figure Canada Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2017
Table Canada Follicle Stimulating Hormone Export and Import (2012-2017)
Figure Mexico Follicle Stimulating Hormone Revenue and Growth (2012-2017)
Figure Mexico Follicle Stimulating Hormone Sales and Growth (2012-2017)
Table Mexico Follicle Stimulating Hormone Sales by Type (2012-2017)
Table Mexico Follicle Stimulating Hormone Sales Market Share by Type (2012-2017)
Table Mexico Follicle Stimulating Hormone Sales by Application (2012-2017)
Table Mexico Follicle Stimulating Hormone Sales Market Share by Application (2012-2017)
Table Mexico Follicle Stimulating Hormone Sales by Manufacturer (2016-2017)
Figure Mexico Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2016
Figure Mexico Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2017
Table Mexico Follicle Stimulating Hormone Revenue by Manufacturer (2016-2017)
Figure Mexico Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2016
Figure Mexico Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2017
Table Mexico Follicle Stimulating Hormone Export and Import (2012-2017)
Figure North America Follicle Stimulating Hormone Sales, Revenue and Growth Rate (2017-2022)
Table North America Follicle Stimulating Hormone Sales Forecast by Countries (2017-2022)
Table North America Follicle Stimulating Hormone Market Share Forecast by Countries (2017-2022)
Figure United States Follicle Stimulating Hormone Sales Forecast (2017-2022)
Figure Canada Follicle Stimulating Hormone Sales Forecast (2017-2022)
Figure Mexico Follicle Stimulating Hormone Sales Forecast (2017-2022)
Table North America Follicle Stimulating Hormone Sales Forecast by Type (2017-2022)
Table North America Follicle Stimulating Hormone Market Share Forecast by Type (2017-2022)
Table North America Follicle Stimulating Hormone Sales Forecast by Application (2017-2022)
Table North America Follicle Stimulating Hormone Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Follicle Stimulating Hormone
Figure Manufacturing Process Analysis of Follicle Stimulating Hormone
Figure Follicle Stimulating Hormone Industrial Chain Analysis
Table Raw Materials Sources of Follicle Stimulating Hormone Major Manufacturers in 2016
Table Major Buyers of Follicle Stimulating Hormone
Table Distributors/Traders/ Dealers List
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
